Loading…
Loading…
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
1 Oct 2026, 11:00 am7d left
Published by the portal on this tender, for queries and grievance redressal.
Pantoprazole 40mg plus Itopride 150mg Tab
Voglibose 0.3 mg Tab
Methergin 0.2 mg Inj
Imipramine 25 mg Tab
Escitalopram 5 mg Tab
Oxybutynin 2.5 mg Tab
Leflunomide Tab 10 mg
Timolol Maletate 0.5 Percentage Preservative Free with comod system
Amiodarone HCI 150 mg ml Inj in 3 ml amp
9898679
GEM/2026/B/8041454
Two Packet Bid
Pantoprazole 40mg plus Itopride 150mg Tab
Dehradun, Uttarakhand
Total value wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
50%
Exempted
Yes
16 Sept 2026
16 Sept 2026
2 Oct 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Pantoprazole 40mg plus Itopride 150mg Tab | 25,500 | No | DEHRADUN | 30 |
| 2 | Voglibose 0.3 mg Tab | 9,900 | No | DEHRADUN | 30 |
| 3 | Methergin 0.2 mg Inj | 180 | Amp | DEHRADUN | 30 |
| 4 | Imipramine 25 mg Tab | 1,350 | No | DEHRADUN | 30 |
| 5 | Escitalopram 5 mg Tab | 6,720 | No | DEHRADUN | 30 |
| 6 | Oxybutynin 2.5 mg Tab | 600 | No | DEHRADUN | 30 |
| 7 | Leflunomide Tab 10 mg | 1,200 | No | DEHRADUN | 30 |
| 8 | Timolol Maletate 0.5 Percentage Preservative Free with comod system | 960 | Vial | DEHRADUN | 30 |
| 9 | Amiodarone HCI 150 mg ml Inj in 3 ml amp | 558 | Amp | DEHRADUN | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9898679.pdf
GEM_BID • 0.15 MB
noting_re-58_2026-09-16-10-32-48_c8ba9fc3602b2938ee85ce662259719c.pdf
BOQ • 0.23 MB
boq_item_sample_file_58_2026-09-16-10-32-48_facaca11491dc93fb6f7989f70da3319.csv
BOQ • 0.00 MB
GEM_OTHER • 2.64 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .